Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by James Mojirade. Insider active across 1 company, notably Avanos Medical, INC.. Aggregated, 13 disclosures have been published. Activity tracked since 20 July 2021. The latest transaction was disclosed on 22 April 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to James Mojirade
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
16,300 shares0Common StockSEC:0001606498-25-000069:0
19,201 shares0Common StockSEC:0001606498-25-000055:0
1,846 shares@ US$15.302.3% of flowCommon StockSEC:0001606498-25-000042:0
8,039 shares0Common StockSEC:0001606498-25-000034:0
684 shares@ US$21.991.2% of flowCommon StockSEC:0001606498-24-000072:0
30,695 shares@ US$19.1447.7% of flowCommon StockSEC:0001606498-24-000038:0
2,190 shares@ US$18.763.3% of flowCommon StockSEC:0001606498-24-000029:0
663 shares@ US$26.151.4% of flowCommon StockSEC:0001606498-23-000058:0
2,111 shares@ US$29.625.2% of flowCommon StockSEC:0001606498-23-000031:1
20,339 shares0Common StockSEC:0001606498-23-000031:0
663 shares@ US$27.411.6% of flowCommon StockSEC:0001872825-22-000002:0
20,233 shares0Common StockSEC:0001606498-22-000034:0
7,308 shares@ US$34.2123.0% of flowCommon StockSEC:0001606498-21-000041:0
About James Mojirade
James Mojirade is a declarant associated with Avanos Medical, INC., where he holds the role of SVP, General Counsel. He has 13 filings in total, and the recent filings tracked cover the period from 2021-07-22 to 2025-04-24; the modal transaction nature is Attribution, with 0 EUR of buys and 0 EUR of sells in this recent sample.